- Home
- BGNE vs NTR Comparison
BGNE vs NTR Comparison
Compare BGNE & NTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGNE
- NTR
- Stock Information
- Founded
- BGNE 2010
- NTR N/A
- Country
- BGNE Cayman Islands
- NTR Canada
- Employees
- BGNE N/A
- NTR N/A
- Industry
- BGNE Biotechnology: Pharmaceutical Preparations
- NTR Agricultural Chemicals
- Sector
- BGNE Health Care
- NTR Industrials
- Exchange
- BGNE Nasdaq
- NTR Nasdaq
- Market Cap
- BGNE 19.2B
- NTR 22.4B
- IPO Year
- BGNE 2016
- NTR N/A
- Fundamental
- Price
- BGNE $175.87
- NTR $44.93
- Analyst Decision
- BGNE Buy
- NTR Buy
- Analyst Count
- BGNE 8
- NTR 16
- Target Price
- BGNE $253.69
- NTR $58.73
- AVG Volume (30 Days)
- BGNE 476.1K
- NTR 1.8M
- Earning Date
- BGNE 11-12-2024
- NTR 11-06-2024
- Dividend Yield
- BGNE N/A
- NTR 4.81%
- EPS Growth
- BGNE N/A
- NTR N/A
- EPS
- BGNE N/A
- NTR 1.48
- Revenue
- BGNE $3,351,304,621.00
- NTR $25,556,000,000.00
- Revenue This Year
- BGNE $969.39
- NTR N/A
- Revenue Next Year
- BGNE $24.79
- NTR $2.30
- P/E Ratio
- BGNE N/A
- NTR $30.38
- Revenue Growth
- BGNE 50.22
- NTR N/A
- 52 Week Low
- BGNE $126.97
- NTR $44.65
- 52 Week High
- BGNE $248.16
- NTR $60.87
- Technical
- Relative Strength Index (RSI)
- BGNE 34.52
- NTR 34.44
- Support Level
- BGNE $174.50
- NTR $47.60
- Resistance Level
- BGNE $180.00
- NTR $49.71
- Average True Range (ATR)
- BGNE 6.73
- NTR 1.06
- MACD
- BGNE -2.17
- NTR -0.21
- Stochastic Oscillator
- BGNE 3.24
- NTR 1.24
About BGNE BeiGene Ltd.
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2023, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 50% of BeiGene's revenue.
About NTR Nutrien Ltd.
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.